Status:
COMPLETED
Effects of Oxytocin and Vasopressin on Moral Decision Making
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making
Detailed Description
In a double-blind, between- subject placebo (PLC) controlled design, subjects will first complete a series of questionnaires in terms of mood, clinical symptoms, and traits. After that their moral jud...
Eligibility Criteria
Inclusion
- healthy subjects without past or current psychiatric or neurological disorders
Exclusion
- pregnancy
Key Trial Info
Start Date :
March 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04890470
Start Date
March 2 2021
End Date
December 12 2022
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiaoxiao Zheng
Sichuan, Sichuan, China, 611731